Furthermore, previous studies also demonstrated that enterocyte-specific deletion of ATX could decrease plasma cholesterol, inhibit systemic inflammation, and reduce atherosclerosis in LDLR−/− mice [37]. Here, ENPP2 is linked to atherosclerosis.